CD19 is a hallmark of B cells and could be used as a target for B cell depletion in the treatment of autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus (SLE). This evidence concerns the gene CD19 and autoimmune disease.